I agree that this site is using cookies. You can find further informations here.
X
Mahadevan, U.
119  results:
Search for persons X
?
1

P1141 Global perspectives on managing Inflammatory Bowel Di..:

Casanova, M J ; Gisbert, J P ; Amiot, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i2042-i2044 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P956 Pregnancy outcomes after maternal or paternal exposure..:

Mahadevan, U ; Chaparro, M ; Segovia Medina, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1735-i1736 , 2024
Link: https://doi.org/10.1093/..
 
?
3

DOP53 Pregnancy outcomes in the ozanimod clinical developme..:

Dubinsky, M C ; Mahadevan, U ; Charles, L...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S088-S089 , 2021
Link: https://doi.org/10.1093/..
 
?
4

Capturing variation impact on molecular interactions in the..:

The IMEx Consortium Curators ; Khadake, J. ; Meldal, B....
Nature Communications.  10 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
5

Publisher Correction: Capturing variation impact on molecul..:

IMEx Consortium contributing authors ; Khadake, J. ; Meldal, B....
Nature Communications.  10 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
6

Letter: vedolizumab drug levels in cord and maternal blood ..:

Mahadevan, U. ; Vermeire, S. ; Lasch, K....
Alimentary Pharmacology & Therapeutics.  48 (2018)  3 - p. 388-389 , 2018
Link: https://doi.org/10.1111/..
 
?
7

Editorial: vedolizumab in pregnancy – is gut selectivity as..:

Mahadevan, U. ; Vermeire, S. ; Lasch, K....
Alimentary Pharmacology & Therapeutics.  45 (2017)  9 - p. 1284-1284 , 2017
Link: https://doi.org/10.1111/..
 
?
8

Vedolizumab exposure in pregnancy: outcomes from clinical s..:

Mahadevan, U. ; Vermeire, S. ; Lasch, K....
Alimentary Pharmacology & Therapeutics.  45 (2017)  7 - p. 941-950 , 2017
Link: https://doi.org/10.1111/..
 
?
9

Cognitive impairment and reduced quality of life among old-..:

Samuel, R. ; McLachlan, C.S. ; Mahadevan, U..
QJM.  109 (2016)  10 - p. 653-659 , 2016
Link: https://doi.org/10.1093/..
 
?
10

Editorial: the management of IBD during pregnancy and lacta..:

Matro, R. ; Mahadevan, U.
Alimentary Pharmacology & Therapeutics.  40 (2014)  10 - p. 1247-1248 , 2014
Link: https://doi.org/10.1111/..
 
?
11

DOP024 Pregnancy outcomes after exposure to certolizumab pe..:

Mahadevan, U. ; Vermeire, S. ; Wolf, D.C....
Journal of Crohn's and Colitis.  8 (2014)  - p. S26 , 2014
Link: https://doi.org/10.1016/..
 
?
12

Ustekinumab in the treatment of Crohn's patients with refra..:

Truta, B ; Terdiman, J ; Mahadevan, U
Inflammatory Bowel Diseases.  17 (2011)  suppl_1 - p. S38-S38 , 2011
Link: https://doi.org/10.1093/..
 
?
13

The IntAct molecular interaction database in 2012:

Kerrien, S. ; Aranda, B. ; Breuza, L....
Nucleic Acids Research.  40 (2011)  D1 - p. D841-D846 , 2011
Link: https://doi.org/10.1093/..
 
?
14

Once daily dosing of delayed-release oral mesalamine for ma..:

Sandborn, W ; Kane, S ; Korzenik, J...
Inflammatory Bowel Diseases.  15 (2009)  - p. S15 , 2009
Link: https://doi.org/10.1097/..
 
?
15

P085 VISILIZUMAB FOR THE TREATMENT OF SUBJECTS WITH INTRAVE..:

Baumgart, D.C. ; Targan, S.R. ; Salzberg, B....
Journal of Crohn's and Colitis Supplements.  1 (2007)  1 - p. 25 , 2007
Link: https://doi.org/10.1016/..
 
1-15